Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

References for PMC Articles for PubMed (Select 21327027)

1.

A method for isolating and analyzing human mRNA from newborn stool.

Bennett WE Jr, Gonz√°lez-Rivera R, Shaikh N, Magrini V, Boykin M, Warner BB, Hamvas A, Tarr PI.

J Immunol Methods. 2009 Sep 30;349(1-2):56-60. doi: 10.1016/j.jim.2009.07.013. Epub 2009 Aug 3.

2.

An efficient RNA extraction method for estimating gut microbial diversity by polymerase chain reaction.

Kang S, Denman SE, Morrison M, Yu Z, McSweeney CS.

Curr Microbiol. 2009 May;58(5):464-71. doi: 10.1007/s00284-008-9345-z. Epub 2009 Jan 22.

PMID:
19159975
3.

Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.

Jones J, Loftus EV Jr, Panaccione R, Chen LS, Peterson S, McConnell J, Baudhuin L, Hanson K, Feagan BG, Harmsen SW, Zinsmeister AR, Helou E, Sandborn WJ.

Clin Gastroenterol Hepatol. 2008 Nov;6(11):1218-24. doi: 10.1016/j.cgh.2008.06.010. Epub 2008 Sep 17.

PMID:
18799360
4.

Predictive biomarkers and signatures in urinary bladder cancer.

Roos PH, Golka K, Hengstler JG.

Curr Opin Mol Ther. 2008 Jun;10(3):243-50. Review.

PMID:
18535931
5.

Metagenomic analysis of human diarrhea: viral detection and discovery.

Finkbeiner SR, Allred AF, Tarr PI, Klein EJ, Kirkwood CD, Wang D.

PLoS Pathog. 2008 Feb 29;4(2):e1000011. doi: 10.1371/journal.ppat.1000011.

6.

Integrating global gene expression analysis and genetics.

Farber CR, Lusis AJ.

Adv Genet. 2008;60:571-601. doi: 10.1016/S0065-2660(07)00420-8. Review.

7.

Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis.

Peterson CG, Sangfelt P, Wagner M, Hansson T, Lettesjö H, Carlson M.

Scand J Clin Lab Invest. 2007;67(8):810-20.

PMID:
18034391
8.

The peripheral-blood transcriptome: new insights into disease and risk assessment.

Mohr S, Liew CC.

Trends Mol Med. 2007 Oct;13(10):422-32. Epub 2007 Oct 4. Review.

PMID:
17919976
9.

Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.

Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, Dobos GJ, Roth J, Foell D.

Gut. 2007 Dec;56(12):1706-13. Epub 2007 Aug 3.

10.

Osteoprotegerin production by human intestinal epithelial cells: a potential regulator of mucosal immune responses.

Vidal K, Serrant P, Schlosser B, van den Broek P, Lorget F, Donnet-Hughes A.

Am J Physiol Gastrointest Liver Physiol. 2004 Oct;287(4):G836-44. No abstract available.

11.

Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome.

Cornick NA, Jelacic S, Ciol MA, Tarr PI.

J Infect Dis. 2002 Jul 1;186(1):57-63. Epub 2002 Jun 10.

12.

Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity.

Greenberg DE, Jiang ZD, Steffen R, Verenker MP, DuPont HL.

J Infect Dis. 2002 Apr 1;185(7):944-9. Epub 2002 Mar 19.

13.

Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection.

de Silva DG, Mendis LN, Sheron N, Alexander GJ, Candy DC, Chart H, Rowe B.

Gut. 1993 Feb;34(2):194-8.

14.

Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea.

Nicholls S, Stephens S, Braegger CP, Walker-Smith JA, MacDonald TT.

J Clin Pathol. 1993 Aug;46(8):757-60.

15.

Cytokines in the stools of children with complicated shigellosis.

Azim T, Halder RC, Sarker MS, Ahmed S, Hamadani J, Chowdhury A, Qadri F, Salam MA, Sack RB, Albert MJ.

Clin Diagn Lab Immunol. 1995 Jul;2(4):492-5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk